Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

NCT06899230 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Resistant Epilepsy
Focal Seizure

Interventions

DRUG: iQ-007
DRUG: Placebo

Sponsor

iQure Australia Pty Ltd

Collaborators

[object Object]